Viewing Study NCT02012192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2026-03-08 @ 5:43 AM
Study NCT ID: NCT02012192
Status: TERMINATED
Last Update Posted: 2019-08-13
First Post: 2013-12-02
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer
Sponsor: Medical University Innsbruck
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epithelial Ovarian Cancer View
None Fallopian Tube Cancer View
None Primary Peritoneal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High-grade serous View
None high-grade endometrioid View
None undifferentiated View